¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå : Á¦Ç° À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº° ¹× Áö¿ªº°
West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region
»óǰÄÚµå
:
1402588
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2023³â 12¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå ±Ô¸ð´Â 2023³â 6¾ï 3,480¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 10¾ï 9,780¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 8.1%·Î Àü¸ÁµË´Ï´Ù.
º¸°í ¹üÀ§ |
º¸°í¼ ¼¼ºÎÁ¤º¸ |
±âÁسâ |
2022³â |
½ÃÀå ±Ô¸ð(2023³â) |
6¾ï 3,480¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2018-2021³â |
¿¹Ãø ±â°£ |
2023-2030³â |
¿¹Ãø ±â°£ÀÇ CAGR |
8.10% |
½ÃÀå ±Ô¸ð ¿¹Ãø(2030³â) |
10¾ï 9,780¸¸ ´Þ·¯ |
±×¸² 1. ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå Áö¿ªº° Á¡À¯À²(%)(2023³â)

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º(WNV)´Â ¸ð±â°¡ ¸Å°³ÇÏ´Â Áúº´À¸·Î Àΰ£, Á¶·ù ¹× ±âŸ µ¿¹°À» °¨¿°½Ãŵ´Ï´Ù. 1937³â ¿ì°£´ÙÀÇ ¿þ½ºÆ® ³ªÀÏ Áö¿ª¿¡¼ óÀ½À¸·Î È®ÀÎµÈ ÀÌ·¡ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ µî ¼¼°è °¢Áö¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º´Â ÁÖ·Î °¨¿°µÈ ¸ð±â¿¡ ¹°·Á¼ »ç¶÷¿¡°Ô °¨¿°µË´Ï´Ù. WNV´Â °¡º¿î ÀÎÇ÷翣ÀÚ¿Í °°Àº Áõ»ó¿¡¼ºÎÅÍ ³ú¿°°ú ¼ö¸·¿°°ú °°Àº ½É°¢ÇÑ ½Å°æ Áúȯ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Áõ»óÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ëºÎºÐÀÇ °¨¿°ÀÚ´Â ¾î¶² Áõ»óµµ ³ªÅ¸³ªÁö ¾ÊÁö¸¸, ¾à 20%´Â ¹ß¿, µÎÅë, ½Åü ÅëÁõ, ¸Þ½º²¨¿ò, ±¸Åä, ¹ßÁøÀ» °æÇèÇÒ ¼ö ÀÖ½À´Ï´Ù. µå¹°°Ô WNV´Â Á×À½À¸·Î À̾îÁö´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ :
¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì¿Í À¯·´¿¡¼ WNV °¨¿°ÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ Áúº´°ú ±× ¿¹¹æ, Áø´Ü¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Áúº´ ¿¹¹æ °ü¸® ¼¾ÅÍ(CDC)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, Àü±¹ °¨½Ã ½Ã½ºÅÛ¿¡ º¸°íµÈ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½Å°æÄ§½À¼º Áúȯ »ç·Ê ¼ö´Â 2021³â 2000¸í À̻󿡼 2022³â 2500¸í ÀÌ»óÀ¸·Î Áõ°¡Çß½À´Ï´Ù. ÅØ»ç½ºÁÖ, ͏®Æ÷´Ï¾ÆÁÖ, ·çÀÌÁö¾Ö³ªÁÖ, ³×ºê¶ó½ºÄ«ÁÖ, Àϸ®³ëÀÌÁÖ µîÀÇ ÁÖ°¡ °¡Àå »ç·Ê ¼ö°¡ ¸¹½À´Ï´Ù. ¹ÙÀÌ·¯½ºÀÇ À¯ÇàÀÌ È®´ëµÇ°í ÀÖ´Â ÀÌÀ¯´Â ±âÈÄ º¯È¿¡ µû¸¥ ±â¿ÂÀÇ »ó½Â¿¡ ÀÇÇØ °¨¿° ½ÃÁðÀÌ ¿¬ÀåµÇ°í ¹ÙÀÌ·¯½º¸¦ È®»ê½ÃŰ´Â ¸ð±âÀÇ Áö¸®Àû ¹üÀ§°¡ È®´ëµÇ°í Àֱ⠶§¹®À̶ó°í »ý°¢µË´Ï´Ù.
±×·¯³ª ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÏ´Â ¿äÀεµ ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ Ä¡·á¹ý°ú ¹é½ÅÀÌ Á¦ÇѵǾî ÀÖ´Â °ÍÀÌ WNV ´ëÃ¥¿¡¼ Å« °úÁ¦ÀÔ´Ï´Ù. Áø´Ü ¹× Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ¹æÇØÇϰí ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸Çϰí, ½ÃÀå ÁøÃâ±â¾÷Àº Ȱ·Î¸¦ ãÀ» ±âȸ°¡ ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦ ±¹°¡¿¡¼ ³ôÀº ¼ºÀå ÀáÀç·Â, È¿°úÀûÀÎ Ä¡·á¹ý °³¹ß ¹× ¸ð±â Á¦°Å ¹æ¹ýÀÇ È°¿ë·üÀÌ Áõ°¡ÇÏ¸é ¼ºÀåÀÇ Å« ±âȸ°¡ µË´Ï´Ù. ¶ÇÇÑ Á¦¾à±â¾÷ ¹× ¿¬±¸±â°üÀÇ Çù·ÂÀ¸·Î WNV¿¡ ´ëÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ßÀÌ °¡¼Ó鵃 ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
- ¶ÇÇÑ ¼·Î ´Ù¸¥ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
- ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¿þ½ºÆ® ³ªÀϹÙÀÌ·¯½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- ÀÌ Á¶»ç º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦ Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- º¸°í¼ ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¿µÇ⠺м®
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
- ¿ªÇÐ
- PEST ºÐ¼®
- Porter's Five Forces ºÐ¼®
- ÇÕº´ ¹× Àμö ½Ã³ª¸®¿À
Á¦4Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ
- ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
- °ø±ÞÃø ¹× ¼ö¿äÃø ºÐ¼®
- °æÁ¦Àû ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Á¦Ç° À¯Çüº°(2018-2030³â)
- Ç×¹ÙÀÌ·¯½ºÁ¦
- ¹é½Å
- Ç×»ýÁ¦
- ÁøÅëÁ¦
- ±âŸ
Á¦6Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Åõ¿© °æ·Îº°(2018-2030³â)
Á¦7Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-À¯Åë ä³Îº°(2018-2030³â)
- º´¿ø ¾à±¹
- ¼Ò¸Å ¾à±¹
- ¿Â¶óÀÎ ¾à±¹
Á¦8Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Áö¿ªº°(2018-2030³â)
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ASEAN
- APAC ±âŸ ±¹°¡
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- Á¦Ç° À¯Çüº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- Åõ¿© °æ·Îº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- À¯Åë ä³Îº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- ±¹°¡º° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- GCC
- À̽º¶ó¿¤
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
- Á¦Ç° À¯Çüº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- Åõ¿© °æ·Îº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- À¯Åë ä³Îº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- ±¹°¡ ¹× Áö¿ªº° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018-2030³â)
- ³²¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
- Áß¾Ó ¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- F.Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Sciences
Á¦10Àå ¼½¼Ç
AJY
¿µ¹® ¸ñÂ÷
The West Nile virus market size is expected to reach US$$ 1,097.8 Mn by 2030, from US$ 634.8 million in 2023, at a CAGR of 8.1% during the forecast period.
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 634.8 Mn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
8.10% |
2030 Value Projection: |
US$ 1,097.8 Mn |
Figure 1. Global West Nile Virus Market Share (%), by Region, 2023

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.
Market Dynamics:
The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.
However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.
Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.
Key features of the study:
- This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market
Detailed Segmentation:
- By Product Type:
- Antivirals
- Vaccines
- Antibiotics
- Analgesics
- Others (Immunoglobulins and among Others)
- By Route of Administration:
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Company Profiles:
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- F.Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Scienes
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global West Nile Virus Market, By Product Type
- Global West Nile Virus Market, By Route of Administration
- Global West Nile Virus Market, By Distribution Channel
- Global West Nile Virus Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- Epidemiology
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
°ü·ÃÀÚ·á